Skip to content Skip to menu

In partnership with key stakeholders, Medicines Australia drives the creation and development of an environment for the continued sustainable growth of the innovative research based prescription medicines industry

About Us

Industry Calls for Reform at Cancer Medicines Inquiry

Medicines Australia and medicines industry representatives have appeared before the Senate Inquiry into the availability of new, innovative and specialist cancer drugs in Australia, calling for improvements to create an optimised, modern, and flexible system to ensure access to cancer medicines for Australians. “Our ability to treat cancer is now far in advance of the…

View article· Monday, 20 April 2015

Pharmaceutical Exports Dive

Latest figures from the Australian Bureau of Statistics show Australian pharmaceutical exports declined by 18 per cent to $2.9 billion in 2014, compared to $3.6 billion in the year before. Since 2012, when they peaked at around $4.3 billion, Australian pharmaceutical exports have declined by more than 30 per cent. “These figures are extremely disappointing,”…

View article· Wednesday, 1 April 2015

Government’s savings on PBS far outweighs investment in new medicines

Analyses released yesterday and today show that government will achieve more than $16 billion in PBS savings from 2010-18, whilst listings of new medicines over this period will cost only $6 billion. The analysis conducted by PharmaDispatch, translates to government savings of more than $2.70 for every $1 spent on new medicines between 2010 and…

View article· Tuesday, 31 March 2015

97 per cent of Aussies want new cancer medicines subsidised through PBS

New findings released by Newspoll [i] shows overwhelming support for access to new cancer medicines through the Pharmaceutical Benefits Scheme (PBS), for Australian patients. Newspoll found 97 per cent of Australians strongly support the subsidisation of cancer medicines for curable cancers, including 95 per cent supporting medicines that ease symptoms and extend the life of…

View article· Tuesday, 24 March 2015

New research shows Australia lags far behind other countries in access to new medicines

A new report released today shows Australians are missing out on too many new medicines,with Australia ranked 18th out of 20 comparable OECD countries. The COMPARE report – Comparison of Access and Reimbursement Environments –benchmarks Australia’s access to new medicines and will be launched at the National Press Club today by Medicines Australia Chairman, Dr…

View article· Wednesday, 18 March 2015

Government and industry partnership key to future of PBS

Medicines Australian Chairman, Dr Martin Cross has welcomed ongoing collaboration between the pharmaceutical industry and Government in addition to further improvements to the Governments post-market review programme, which was announced today by the Minister for Health, the Hon Sussan Ley.  “This framework for post-market reviews is the result of collaboration between the Government and Medicines…

View article· Wednesday, 18 March 2015

Fear Mongering Jeopardising “21st Century” Trade Deal

The Trans Pacific Partnership Agreement (TPP) will open up vast new markets for Australian companies, including manufacturers of innovative medicines and vaccines, Medicines Australia CEO, Tim James, said today.  “Pharmaceuticals are already one of Australia’s largest manufactured export, worth around $3 billion each year.  “But a new trade deal which further reduces trade barriers, improves…

View article· Monday, 16 March 2015

Medicines Australia presents Ethics Awards for top sales representatives

Thirteen medical sales representatives from the Australian medicines industry received the sector’s top accolade for ethical sales and marketing at a ceremony yesterday. The Medicines Australia Continuing Education Program Awards are presented annually to sales representatives who achieve the best marks in their compulsory ethical conduct education program. Medicines Australia Chief Executive Officer, Mr Tim…

View article· Friday, 13 March 2015

IGR confirms the sustainability of the PBS into the future

The release of the highly anticipated 2015 Intergenerational Report (IGR) today reaffirmed the growing body of evidence that shows that the Pharmaceutical Benefits Scheme (PBS) is sustainable. CEO of Medicines Australia, Tim James, welcomed the release of the Australian Government’s 2015 IGR, and its acknowledgement that growth in pharmaceutical expenditure will remain stable, growing only…

View article· Thursday, 5 March 2015

Australian cancer patients in deadly wait for new medicines

Australian cancer patients don’t have time to wait for access to new cancer medicines. Australian patients wait longer for access to new cancer medicines compared to patients in other parts of the world, such as the United Kingdom, Canada, France and Germany. “Australia is the cancer capital of the world.  We are now living much…

View article· Thursday, 26 February 2015

Papers, Reports & Submissions


Agreements, Indemnity & Compensation Guidelines

Clinical Trials

Awards, Speeches & Media Releases

Media & Events

Member company lounge

Member's Area

Sign up for updates

Sign up for email updates to keep on top of Medicines Australia developments.


Industry Calls for Reform at Cancer Medicines Inquiry

RT @bodyandsoul_au: RT @MedicinesAus: Why do Australians wait longer than most for life-saving medicine? See @bodyandsoul_au article http:/…

Time for another cuppa @MedicinesAus as Aussie barista wins World Barista Championship - Congrats to @SasaSestic of #CANBERRA #WBC2015

Why do Australians wait longer than most for life-saving medicine? See @bodyandsoul_au article

Recruiting for outstanding Comms Director for @MedicinesAus. Very high level experience req. Move quickly if keen.

RT @timothycjames: Farewelling @MedicinesAus Industry Policy Manager Omar Khan today after 7 years service - congrats and thanks Omar! http…

#WorldHealthDay2015 food safety can prevent outbreaks of disease, be healthy!

RT @heatinformatics: Proportion of new medicines reimbursed, 2009-2014 vs. healthcare spending per capita (2013) @MedicinesAus…

Iconic buildings across Australia will turn their lights blue today to promote World Autism Awareness Day 2015 #LIUB

RT @PharmaInFocusAu: News: @ABSStats show Aussie #pharma exports decline by 18% in 2014, down $700M on 2013 says @MedicinesAus' @timothycja

Government’s savings on PBS far outweighs investment in new medicines

RT @MMMXXX: MA Board. With James Priour just outside Exeter #medicinesaustralia